These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 10852183)
1. Bone turnover in children with vitamin D deficiency rickets before and during treatment. Baroncelli GI; Bertelloni S; Ceccarelli C; Amato V; Saggese G Acta Paediatr; 2000 May; 89(5):513-8. PubMed ID: 10852183 [TBL] [Abstract][Full Text] [Related]
2. Vitamin D supplementation to healthy children does not affect serum osteocalcin or markers of type I collagen turnover. Schou AJ; Heuck C; Wolthers OD Acta Paediatr; 2003 Jul; 92(7):797-801. PubMed ID: 12892157 [TBL] [Abstract][Full Text] [Related]
3. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen. Katagiri M; Fukunaga M; Ohtawa T; Harada T World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946 [TBL] [Abstract][Full Text] [Related]
4. Does vitamin D administered to children with asthma treated with inhaled glucocorticoids affect short-term growth or bone turnover? Schou AJ; Heuck C; Wolthers OD Pediatr Pulmonol; 2003 Nov; 36(5):399-404. PubMed ID: 14520722 [TBL] [Abstract][Full Text] [Related]
5. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis. Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479 [TBL] [Abstract][Full Text] [Related]
6. Variable efficacy of bone remodeling biochemical markers in the management of patients with Paget's disease of bone treated with tiludronate. de la Piedra C; Rapado A; Díaz Diego EM; Díaz Martín MA; Aguirre C; López Gavilanes E; Díaz Curiel M Calcif Tissue Int; 1996 Aug; 59(2):95-9. PubMed ID: 8687976 [TBL] [Abstract][Full Text] [Related]
7. [Studies of type I collagen related substances as bone metastatic markers of prostate carcinoma with special regard to serum carboxyterminal propeptide of type. I. Procollagen (PICP), cross-linked carboxyterminal telopeptide of type I collagen (ICTP) and Urinary deoxypyridinoline levels]. Imai T; Honda M; Maeda S; Hosoya Y; Arai T; Sumi S; Umeda H; Yano M; Koga F; Arai K; Yoshida K Nihon Hinyokika Gakkai Zasshi; 1998 Apr; 89(4):484-91. PubMed ID: 9597867 [TBL] [Abstract][Full Text] [Related]
8. A cross-sectional study on biochemical parameters of bone turnover and vitamin d metabolites in healthy dutch children and young adults. van der Sluis IM; Hop WC; van Leeuwen JP; Pols HA; de Muinck Keizer-Schrama SM Horm Res; 2002; 57(5-6):170-9. PubMed ID: 12053089 [TBL] [Abstract][Full Text] [Related]
9. Dynamics of bone turnover in children with GH deficiency treated with GH until final height. Baroncelli GI; Bertelloni S; Ceccarelli C; Cupelli D; Saggese G Eur J Endocrinol; 2000 Jun; 142(6):549-56. PubMed ID: 10822216 [TBL] [Abstract][Full Text] [Related]
11. Increased degradation of type I collagen in patients with inflammatory bowel disease. Silvennoinen J; Risteli L; Karttunen T; Risteli J Gut; 1996 Feb; 38(2):223-8. PubMed ID: 8801201 [TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer. Akimoto S; Akakura K; Shimazaki J Jpn J Clin Oncol; 1996 Jun; 26(3):157-63. PubMed ID: 8656556 [TBL] [Abstract][Full Text] [Related]
13. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients. Lee SH; Huang TS; Hsieh SJ Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625 [TBL] [Abstract][Full Text] [Related]
14. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency. Bollerslev J; Møller J; Thomas S; Djøseland O; Christiansen JS Eur J Endocrinol; 1996 Dec; 135(6):666-71. PubMed ID: 9025710 [TBL] [Abstract][Full Text] [Related]
15. Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen (ICTP). Nordic Myeloma Study Group (NMSG). Abildgaard N; Bentzen SM; Nielsen JL; Heickendorff L Br J Haematol; 1997 Jan; 96(1):103-10. PubMed ID: 9012695 [TBL] [Abstract][Full Text] [Related]
16. Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men. Gram J; Junker P; Nielsen HK; Bollerslev J Bone; 1998 Sep; 23(3):297-302. PubMed ID: 9737353 [TBL] [Abstract][Full Text] [Related]
17. Serum levels of cross-linked N-telopeptides and aminoterminal propeptides of type I collagen indicate low bone mineral density in elderly women. Scariano JK; Glew RH; Bou-Serhal CE; Clemens JD; Garry PJ; Baumgartner RN Bone; 1998 Nov; 23(5):471-7. PubMed ID: 9823455 [TBL] [Abstract][Full Text] [Related]
18. New markers of bone and collagen turnover in children and adults with growth hormone deficiency. Sartorio A; Conti A; Monzani M Postgrad Med J; 1993 Nov; 69(817):846-50. PubMed ID: 8290428 [TBL] [Abstract][Full Text] [Related]
19. Serum levels of the pyridinoline crosslinked carboxyterminal telopeptide of type I collagen (ICTP) and osteocalcin in rachitic children in Nigeria. Scariano JK; Walter EA; Glew RH; Hollis BW; Henry A; Ocheke I; Isichei CO Clin Biochem; 1995 Oct; 28(5):541-5. PubMed ID: 8582054 [TBL] [Abstract][Full Text] [Related]
20. Characteristics of biochemical markers in patients with metabolic bone disorders. Hoshino H; Kushida K; Takahashi M; Kawana K; Denda M; Yamazaki K; Inoue T Endocr Res; 1998 Feb; 24(1):55-64. PubMed ID: 9553754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]